With the removal of cisapride from the U.S. market, practitioners have increasingly used other medications, such as metoclopramide, to treat gastroesophageal reflux in pediatric patients. We describe the case of a neonate who developed methemoglobinemia after receiving metoclopramide at doses slightly above the recommended age-appropriate dosage. Health care providers should be aware of this potentially serious side effect in young infants who receive this medication.
Methemoglobinemia Associated with Metoclopramide Therapy in a Neonate
Kristine G. Palmer, Laura P. James; Methemoglobinemia Associated with Metoclopramide Therapy in a Neonate. The Journal of Pediatric Pharmacology and Therapeutics 1 January 2004; 9 (1): 49–54. doi: https://doi.org/10.5863/1551-6776-9.1.49
Download citation file: